Stephen Andrew Welch - EVP & Head of Spec Generics at Keenova Therapeutics plc

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & Head of Spec Generics
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen Andrew Welch since 03 Feb 2025

Holdings reported by Stephen Andrew Welch for Keenova Therapeutics plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 3,631 $37.50 01 Jan 2025 Direct
Restricted Stock Units 0 10 Nov 2025 Direct Ordinary Shares

Transactions reported by Stephen Andrew Welch for Keenova Therapeutics plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.